Inside the proton, quarks and gluons shift and morph their properties in ways that physicists are still struggling to ...

This was the stock's second consecutive day of losses.

Stock analysts at Guggenheim started coverage on shares of Quanta Services (NYSE:PWR – Get Free Report) in a research report ...

Fintel reports that on January 8, 2025, Guggenheim initiated coverage of Quanta Services (NYSE:PWR) with a Neutral ...

Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...

Quanta Services (NYSE:PWR) on Wednesday was rated Neutral in new research coverage by analysts at financial-services firm ...

Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...

That number should rise significantly in the coming years. Forecasters estimate that the U.S. will deploy 375-450 gigawatts ...

First Hawaiian Bank raised its position in Quanta Services, Inc. (NYSE:PWR – Free Report) by 62.2% in the fourth quarter, ...

As previously reported, Guggenheim initiated coverage of Quanta Services (PWR) with a Neutral rating and no price target At $24B in 2024 ...

Shares of Quanta Services Inc. PWR shed 2.51% to $319.81 Tuesday, on what proved to be an all-around dismal trading session ...